Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Tilray Stock Is Having A Green Day: What's Going On?

Tilray Stock Is Having A Green Day: What's Going On?

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Chart Wars: Between Tilray And Canopy Growth, Which Cannabis Stock Could Slam Shorts Harder?

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) soared 10.59% and 8.76%, respectively, on Monday.

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers.

EXCLUSIVE: Why One Top Hedge Fund Manager Is Bullish On US Cannabis Stocks

Investment expert and former hedge fund manager Whitney Tilson, current president and CEO of Empire Financial Research, recently stopped by Benzinga Cannabis Hour to discuss his investment thesis including his 2022 outlook as it pertains to the

Best Marijuana Stocks to Buy: Cannabis Stocks for Investing

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

inkl

Read news from The Economist, FT, and more,
with one subscription

1 2 3 4 5

People

Charles E. Schumer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Canopy Growth Corporation

Tilray Brands, Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

243,105 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play